BiomX Inc., a clinical-stage company listed on NYSE American under the symbol PHGE, recently released its financial results for the third quarter ending September 30, 2024, along with significant ...
“Today's LCD decision recognizes the importance of clinical trial data and real-world evidence in shaping policies that affect all patients,” stated Gary S. Gillheeney, Sr., President, Chief Executive ...